Sleeping BeautyTransposon-Mediated Transfection of Retinal and Iris Pigment Epithelial Cells
Author(s) -
Sandra Johnen,
Zsuzsanna Izsvák,
Michael Stöcker,
Nina Harmening,
Anna Katharina Salz,
Peter Walter,
Gabriele Thumann
Publication year - 2012
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.12-9951
Subject(s) - pedf , transfection , biology , microbiology and biotechnology , sleeping beauty transposon system , genetic enhancement , retinal , gene delivery , neuroprotection , immunology , cancer research , angiogenesis , gene , transposable element , genetics , pharmacology , biochemistry , genome
Subretinal transplantation of retinal (RPE) or iris (IPE) pigment epithelial cells has been advocated as a treatment for retinal degeneration. However, to our knowledge, in patients with age-related macular degeneration no significant beneficial effects on vision have been shown. Since the transplanted cells did not appear to maintain a healthy avascular and neuroprotective environment, we postulate that it will be necessary to transplant cells that express elevated levels of anti-angiogenic and neuroprotective activities. In our study, we provide a protocol for the efficient stable gene transfer and sustained gene expression of pigment epithelium-derived factor (PEDF), a potent anti-angiogenic and neuroprotective factor, using the nonviral Sleeping Beauty transposon system (SB100X).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom